PATH transforms diagnostic technologies to promote optimal health outcomes in low-resource settings. We make high-impact, affordable diagnostic tools available, accessible, and adoptable.
As part of multi-pronged eradication efforts, PATH is advancing a rapid diagnostic screening test to help detect a class of rare genetic diseases that presents a unique risk for spreading the poliovirus.
PATH is helping innovators translate good ideas into lasting impact
Low-cost, simple, point-of-care blood tests for G6PD enzyme deficiency are a key part of Plasmodium vivax malaria treatment, and a step towards eliminating malaria overall
New rapid point of care diagnostic tests for malaria can identify patients who have few symptoms, but carry the malaria parasite nonetheless
A new multiplexed immunoassay enables simultaneous, cost-effective population surveillance for micronutrient deficiencies and health conditions using just a drop of blood
New rapid diagnostic tests for onchocerciasis (river blindness) and lymphatic filariasis will guide surveillance of mass drug administration programs needed for elimination.
Subscribe to DxNEWS to receive periodic updates and information from the PATH Diagnostics program.
Browse resources and publications from our program in the PATH resource database.